Korean J Psychopharmacol.  2004 Sep;15(3):276-283.

The Consideration for Revision of the Korean Medication Algorithm for Schizophrenia

Affiliations
  • 1Department of Psychiatry, College of Medicine, Hallym University, Seoul, Korea.
  • 2Department of Psychiatry, Seoul National University College of Medicine, Seoul, Korea. Kwonjs.plaza.snu.ac.kr
  • 3Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Abstract

After publishing 2001 version of the Korean Medication Algorithm for Schizophrenia, the strategy of pharmacologic treatment for schizophrenia has been altered with the rapid advancement in the area of psychopharmacology. Currently, the feasibility of this algorithm has been evaluated. Guidelines require updating when significant new evidence appears. Recently, several guidelines of the treatment of schizophrenia including the APA practice guideline, the Expert Consensus Guideline Series and the Texas Medication Algorithm Project (TMAP) Antipsychotic Algorithm for Schizophrenia were revised. In this review, the authors briefly discussed the problems and limitations of the Korean Medication Algorithm for Schizophrenia and presented the direction of future revision on the model of above-mentioned guidelines.

Keyword

Korean medication algorithm for schizophrenia; Pharmacotherapy; Revision
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr